HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INNOGEN-B

4.005

-0.040-0.99%

Volume:3.26M

Turnover:12.98M

Market Cap:1.83B

PE:-4.34

High:4.095

Open:4.095

Low:3.910

Close:4.045

52wk High:48.360

52wk Low:3.435

Shares:457.00M

HK Float Shares:420.29M

Volume Ratio:0.53

T/O Rate:0.77%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.923

ROE:-41.16%

ROA:-20.15%

PB:1.66

PE(LYR):-4.34

PS:10.22

Loading ...

Overview Company News Filings

Innogen Pharmaceutical posts 2025 maiden revenue of RMB131.51 million; net loss widens on surging R&D and commercial spend

Bulletin Express

Guangzhou Innogen Pharmaceutical - Plans to Enter the Latin America Market

THOMSON REUTERS

Guangzhou Innogen Pharmaceutical - FY Revenue RMB131.5 Mln

THOMSON REUTERS

Guangzhou Innogen launches esupaglutide α for T2D in China, posting CNY 132 million in 2025 revenue

Guangzhou Innogen FY2025 net loss widens 95.4% to RMB341 million as selling and distribution expenses surge to RMB177 million

Innogen Pharmaceutical revises corporate secretarial lineup, obtains continued waiver under HKEX Listing Rules

Bulletin Express

INNOGEN-B (02591) Appoints Mak Po Man as Joint Company Secretary

Guangzhou Innogen appoints Mak Po Man Cherie as joint company secretary, replacing Sze Suet Ling

INNOGEN-B Shares Drop Over 5% Intraday as Annual Loss Expected to Reach Approximately 341.4 Million Yuan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/02591/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"INNOGEN-B","latestPrice":4.005,"timestamp":1789441729852,"preClose":4.045,"halted":0,"volume":3256000,"delay":0,"changeRate":-0.009888751545117438,"floatShares":420285370,"shares":457000000,"eps":-0.9233540918288915,"marketStatus":"Trading","change":-0.04,"latestTime":"09-15 11:08:51","open":4.095,"high":4.095,"low":3.91,"amount":12978425,"amplitude":0.045735,"askPrice":4.02,"askSize":9800,"bidPrice":4.005,"bidSize":1800,"shortable":3,"etf":0,"ttmEps":-0.8610627547098778,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789444800000},"marketStatusCode":2,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":4.045,"openAndCloseTimeList":[[1789435800000,1789444800000],[1789448400000,1789459200000]],"volumeRatio":0.529494,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-20.15%","roe":"-41.16%","lyrEps":-0.923354,"volumeRatio":0.529494,"shares":457000000,"dividePrice":0,"high":4.095,"amplitude":0.045735,"preClose":4.045,"low":3.91,"week52Low":3.435,"pbRate":"1.66","psRate":"10.22","week52High":48.36,"institutionHeld":0,"latestPrice":4.005,"committee":-0.689655,"eps":-0.9233540918288915,"divideRate":0,"volume":3256000,"delay":0,"ttmEps":-0.8610627547098778,"open":4.095,"prevYearClose":30.64,"prevWeekClose":3.99,"prevMonthClose":3.635,"prevQuarterClose":7.09,"fiveDayClose":3.695,"twentyDayClose":4.49,"sixtyDayClose":7.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02591","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775923200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-09-14","current":-4.651229,"percent":0.950758,"low":-137.156472,"twenty":-66.864688,"median":-47.228587,"eighty":-11.369513,"high":-4.018047,"avg":-43.222778,"sd":30.647841,"marketCap":1847834266},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327},{"date":"2026-02-13","current":-50.165477,"twenty":-79.691019,"median":-62.941647,"eighty":-57.039695,"marketCap":12608214032},{"date":"2026-02-20","current":-50.419859,"twenty":-79.623791,"median":-62.643943,"eighty":-56.891323,"marketCap":12653895967},{"date":"2026-02-27","current":-50.052949,"twenty":-79.470699,"median":-62.017016,"eighty":-56.651056,"marketCap":12699577902},{"date":"2026-03-06","current":-43.88908,"twenty":-79.397543,"median":-60.902753,"eighty":-56.29247,"marketCap":11045891858},{"date":"2026-03-13","current":-39.965904,"twenty":-79.214462,"median":-60.292057,"eighty":-54.71959,"marketCap":10104843999},{"date":"2026-03-20","current":-39.174717,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"marketCap":9867297938},{"date":"2026-03-27","current":-24.701097,"twenty":-78.775514,"median":-59.491697,"eighty":-50.290678,"marketCap":9547524394},{"date":"2026-04-02","current":-24.535908,"twenty":-78.383597,"median":-58.823921,"eighty":-50.052949,"marketCap":9529251620},{"date":"2026-04-10","current":-24.978414,"twenty":-78.348547,"median":-58.584467,"eighty":-49.631191,"marketCap":9775934068},{"date":"2026-04-17","current":-23.474521,"twenty":-78.227102,"median":-58.112982,"eighty":-48.421657,"marketCap":9191205301},{"date":"2026-04-24","current":-19.658213,"twenty":-78.155492,"median":-57.844151,"eighty":-44.116877,"marketCap":7697406030},{"date":"2026-04-30","current":-16.329046,"twenty":-77.825679,"median":-57.660489,"eighty":-41.074266,"marketCap":6395470886},{"date":"2026-05-08","current":-17.822364,"twenty":-77.322024,"median":-57.626503,"eighty":-40.478309,"marketCap":5778764764},{"date":"2026-05-15","current":-17.368107,"twenty":-77.157551,"median":-57.517602,"eighty":-40.012158,"marketCap":5646287153},{"date":"2026-05-22","current":-17.112125,"twenty":-76.782452,"median":-57.446424,"eighty":-25.37304,"marketCap":5550355090},{"date":"2026-05-29","current":-15.607197,"twenty":-76.252433,"median":-57.23775,"eighty":-24.916387,"marketCap":5079831160},{"date":"2026-06-05","current":-14.014909,"twenty":-75.020932,"median":-57.073515,"eighty":-24.414835,"marketCap":4568193490},{"date":"2026-06-12","current":-11.752443,"twenty":-74.621039,"median":-56.924891,"eighty":-23.900197,"marketCap":3828146144},{"date":"2026-06-18","current":-10.549084,"twenty":-74.404407,"median":-56.73827,"eighty":-23.474521,"marketCap":3444417891},{"date":"2026-06-26","current":-9.60263,"twenty":-74.160764,"median":-56.642046,"eighty":-20.865982,"marketCap":3120076153},{"date":"2026-07-03","current":-11.351574,"twenty":-74.088566,"median":-56.533624,"eighty":-19.581214,"marketCap":3691100339},{"date":"2026-07-10","current":-11.238926,"twenty":-74.037218,"median":-56.208644,"eighty":-19.055481,"marketCap":3649986598},{"date":"2026-07-17","current":-10.540302,"twenty":-73.42668,"median":-55.144116,"eighty":-17.753872,"marketCap":3435281504},{"date":"2026-07-24","current":-10.636027,"twenty":-71.947117,"median":-53.621015,"eighty":-17.028947,"marketCap":3467258858},{"date":"2026-07-31","current":-10.1543,"twenty":-71.465685,"median":-51.153424,"eighty":-16.590446,"marketCap":3316508473},{"date":"2026-08-07","current":-10.609247,"twenty":-70.999854,"median":-50.412223,"eighty":-15.817726,"marketCap":3471827052},{"date":"2026-08-14","current":-9.215586,"twenty":-70.625283,"median":-50.222782,"eighty":-14.020929,"marketCap":3019575896},{"date":"2026-08-21","current":-5.675745,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"marketCap":1863822943},{"date":"2026-08-28","current":-4.445704,"twenty":-68.330506,"median":-49.617462,"eighty":-11.852702,"marketCap":1733629429},{"date":"2026-09-04","current":-4.209722,"twenty":-67.634909,"median":-49.247121,"eighty":-11.642751,"marketCap":1642265559},{"date":"2026-09-11","current":-4.665967,"twenty":-67.023292,"median":-47.343126,"eighty":-11.381044,"marketCap":1822709202},{"date":"2026-09-14","current":-4.730389,"twenty":-66.864688,"median":-47.228587,"eighty":-11.369513,"marketCap":1847834266}],"updateTime":1789441731925},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1190961010","title":"Innogen Pharmaceutical posts 2025 maiden revenue of RMB131.51 million; net loss widens on surging R&D and commercial spend","url":"https://stock-news.laohu8.com/highlight/detail?id=1190961010","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190961010?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:02","pubTimestamp":1774278135,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group (Innogen-B) released its first post-IPO annual results, highlighting the transition from pure R&D to simultaneous development and commercialisation. Revenue and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621870210","title":"Guangzhou Innogen Pharmaceutical - Plans to Enter the Latin America Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2621870210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621870210?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:55","pubTimestamp":1774277747,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0AT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621021447","title":"Guangzhou Innogen Pharmaceutical - FY Revenue RMB131.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2621021447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621021447?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:55","pubTimestamp":1774277747,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621702129","title":"Guangzhou Innogen launches esupaglutide α for T2D in China, posting CNY 132 million in 2025 revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2621702129","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621702129?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:55","pubTimestamp":1774277731,"startTime":"0","endTime":"0","summary":"Innogen reported the China approval and commercial launch of its core product, yisupaglutide α, for adult type 2 diabetes, marking a shift toward a combined R&D-and-commercial model.National reimbursement listing for the adult type 2 diabetes indication is scheduled to take effect on Jan. 1, 2026, which may expand patient access and support broader hospital uptake.The company said it is pursuing lifecycle expansion into weight management and MASH, targeting additional revenue streams beyond the initial diabetes market.Overseas filings were submitted in Hong Kong and selected markets in Southeast Asia and Latin America, positioning the product for potential regional commercialization partnerships.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL4htKm7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621702126","title":"Guangzhou Innogen FY2025 net loss widens 95.4% to RMB341 million as selling and distribution expenses surge to RMB177 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621702126","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621702126?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:55","pubTimestamp":1774277727,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen FY2025 net loss widens 95.4% to RMB341 million as selling and distribution expenses surge to RMB177 million. Innogen published an annual results announcement for the year ended Dec. 31, 2025.Revenue was RMB131.5 million, while gross profit was RMB117.1 million.Loss for the year widened to RMB341.4 million, and basic and diluted loss per share was RMB0.79.Research and development expenses rose 100.7% to RMB205.8 million, driven by higher pre-clinical and clinical trial and process optimization fees and higher raw materials costs tied to Efsubaglutide Alfa.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via II","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL6kt3KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180017707","title":"Innogen Pharmaceutical revises corporate secretarial lineup, obtains continued waiver under HKEX Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=1180017707","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180017707?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:23","pubTimestamp":1774268588,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (Innogen Pharmaceutical) announced several governance adjustments effective 23 March 2026. Joint Company Secretary Sze Suet Ling will resign from her...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112376071","title":"INNOGEN-B (02591) Appoints Mak Po Man as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1112376071","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112376071?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:10","pubTimestamp":1774267820,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that Ms. Shi Xueling has resigned from her positions as (i) Joint Company Secretary of the Company, (ii) the Company's Authorized Representative for accepting service of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621703329","title":"Guangzhou Innogen appoints Mak Po Man Cherie as joint company secretary, replacing Sze Suet Ling","url":"https://stock-news.laohu8.com/highlight/detail?id=2621703329","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621703329?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:05","pubTimestamp":1774267514,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen said Suet Ling Sze resigned as joint company secretary, agent for service of process, and authorized representative, effective March 23, 2026.Mak is vice president of SWCS Corporate Services Group  and has over 20 years of experience in audit, accounting, corporate finance, compliance, and corporate secretarial work.Dongyan Yang will continue as the other joint company secretary and has served as the group’s legal director since April 2021.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 23, 2026, and is solely respon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL97VtGk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163444545","title":"INNOGEN-B Shares Drop Over 5% Intraday as Annual Loss Expected to Reach Approximately 341.4 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1163444545","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163444545?lang=en_us&edition=fundamental","pubTime":"2026-03-20 11:57","pubTimestamp":1773979053,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) fell more than 5% during trading, and as of the latest update, the decline was 2.17%, with the share price at HK$21.62 and a turnover of HK$3.98 million. On March 18, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VXUS","BK4588","02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":109,"code":"91000000","status":"200"}]}}